Energy Focus, Inc. Appoints Larry Fallon as Senior Vice President of Sales and Marketing
May 02, 2017 12:00 pm UTC| Business
SOLON, Ohio, May 02, 2017 -- Energy Focus, Inc. (NASDAQ:EFOI) a leader in energy-efficient LED lighting technologies, today announced the appointment of Larry Fallon as its Senior Vice President of Sales and Marketing....
Study Illustrates Vulnerability in Digital Email Verifications
May 02, 2017 12:00 pm UTC| Business
EUGENE, OR, May 02, 2017 -- Today, SheerID, the leader in eligibility verification software preferred by enterprises organizations, released data from a recent survey of over 375 college alumni in the US focusing on the...
May 02, 2017 12:00 pm UTC| Business
NCI Currently Conducting Clinical Trials with LMB-100LMB-100 and SVP-Rapamycin Combination Treatment Enhances Anti-Tumor Activity in Preclinical Models Selecta and NCI in Discussions Regarding Phase 1b Trial of Combination...
Proofpoint to Present at Jefferies Technology Group 2017 Global Technology Conference
May 02, 2017 12:00 pm UTC| Business
SUNNYVALE, Calif., May 02, 2017 -- Proofpoint, Inc. (NASDAQ:PFPT), a leading next-generation cybersecurity company, today announced that Manish Sarin, executive vice president, corporate planning development, and Jason...
May 02, 2017 11:45 am UTC| Business
Hollywood, May 02, 2017 -- Earth Science Tech, Inc. (OTC PINK: ETST), an innovative biotech company focused on cannabis CBD-based (industrial hemp), cannabinoid research and development, nutraceuticals, pharmaceuticals,...
Global Cheese Market Share Expected to Hit $124.20 Billion by 2022: Zion Market Research
May 02, 2017 11:43 am UTC| Business
Sarasota, FL, May 02, 2017 -- Zion Market Research has published a new report titled “Cheese Market (Natural and Processed) by Product (Mozzarella, Cheddar, Feta, Roquefort and Others): Global Industry Perspective,...
Amicus Therapeutics Launches Galafold™ (Migalastat) for Treatment of Fabry Disease in France
May 02, 2017 11:31 am UTC| Business
CRANBURY, N.J. and PARIS, May 02, 2017 -- Amicus Therapeutics (Nasdaq:FOLD), a global biotechnology company at the forefront of rare and orphan diseases, has commenced the commercial launch of the precision medicine...
Trump Floats Greenland Framework, Bets Big on ‘Mission 500’ With India